Testing effectiveness (Phase 2)Looking for participantsNCT07089992What this trial is testingPembrolizumab in People With Ultra-Rare SarcomasWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT04996004What this trial is testingLearn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaWho this might be right forLeiomyosarcoma Pfizer 76
Early research (Phase 1)Study completedNCT04242238What this trial is testingStudy of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasWho this might be right forSarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571What this trial is testingTesting Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue SarcomaWho this might be right forLocally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more National Cancer Institute LAO 66
Large-scale testing (Phase 3)Not Yet RecruitingNCT07823491What this trial is testingPembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk WallWho this might be right forResectable LiposarcomaResectable Soft Tissue SarcomaResectable Undifferentiated Pleomorphic Sarcoma Ohio State University Comprehensive Cancer Center 228
Early research (Phase 1)Looking for participantsNCT05711615What this trial is testingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaWho this might be right forMetastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Ended earlyNCT04979442What this trial is testingTreatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated LiposarcomaWho this might be right forDedifferentiated Liposarcoma Rain Oncology Inc 175
Not applicableUnknownNCT02983539What this trial is testingDetection of Circulating Tumor Cells in Patients With SarcomasWho this might be right forLeiomyosarcomaPleomorphic LiposarcomaSynovial Sarcoma+1 more AC Camargo Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT02180867What this trial is testingRadiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryWho this might be right forAlveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741877What this trial is testingLifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue SarcomaWho this might be right forSarcomaSoft Tissue Sarcoma (STS)Advanced Soft Tissue Sarcoma+2 more Iovance Biotherapeutics, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT03899805What this trial is testingA Phase II Study of Eribulin and Pembrolizumab in Soft Tissue SarcomasWho this might be right forSarcomaLiposarcomaLeiomyosarcoma+1 more Dana-Farber Cancer Institute 57
Testing effectiveness (Phase 2)UnknownNCT03651375What this trial is testingHypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallWho this might be right forSarcomaFibrosarcomaLeiomyosarcoma+14 more Maria Sklodowska-Curie National Research Institute of Oncology 46
Testing effectiveness (Phase 2)UnknownNCT04356872What this trial is testingThe Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Fudan University 45
Early research (Phase 1)Active Not RecruitingNCT04420975What this trial is testingNivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaWho this might be right forLeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01653028What this trial is testingAlisertib in Treating Patients With Advanced or Metastatic SarcomaWho this might be right forMyxofibrosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Leiomyosarcoma+5 more National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Study completedNCT02451943What this trial is testingDoxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue SarcomaWho this might be right forSoft Tissue Sarcoma Eli Lilly and Company 509
Testing effectiveness (Phase 2)Looking for participantsNCT06277154What this trial is testingMASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaWho this might be right forLeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more HRYZ Biotech Co. 148
Testing effectiveness (Phase 2)Study completedNCT00025441What this trial is testingCombination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsWho this might be right forOvarian CancerSarcomaSmall Intestine Cancer Societe Internationale d'Oncologie Pediatrique
Testing effectiveness (Phase 2)Study completedNCT02500797What this trial is testingNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by SurgeryWho this might be right forLocally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923778What this trial is testingTalimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by SurgeryWho this might be right forLeiomyosarcomaLiposarcomaSarcoma G2+6 more National Cancer Institute (NCI) 40